Nkarta, Inc. (NKTX)
3.145
-0.18
(-5.27%)
USD |
NASDAQ |
May 07, 16:00
3.145
0.00 (0.00%)
After-Hours: 20:00
Nkarta Total Assets (Quarterly) : 417.29M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 1.107B |
| Inovio Pharmaceuticals, Inc. | 75.68M |
| ADMA Biologics, Inc. | 633.35M |
| Cullinan Therapeutics, Inc. | 449.14M |
| Zenas BioPharma, Inc. | 383.64M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 104.97M |
| Shareholders Equity (Quarterly) | 312.32M |
| Debt to Equity Ratio | 0.2447 |
| Current Ratio | 12.69 |
| Net Debt Paydown Yield | 1.37% |